Search | TVST | ARVO Journals

Showing 1 – 20 of 82

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Employing Large Language Models (LLMs) for study candidate selection and clinical data extraction in the context of retinal research.

Luis Hernandez; Hugo Quiroz-Mercado; Jans Fromow-Guerra

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):345.

ARVO Annual Meeting Abstract June 2023

SAFETY PROFILE OF SUBRETINAL INJECTION OF HUMAN AMNIOTIC MEMBRANE UMBILICAL CORD PARTICULATE IN PIGS

Rodrigo Garcia-Santisteban; Jimena Gonzalez Salido; Vidal Soberon-Ventura; Abelardo Rodriguez-Reyes; Pedro Chouciño-Brindis; Gustavo Del Castillo-Marquez; Jessica Serrano-Aguilar; Elizabeth Rueda-Torres; Samuel Peña-Ortiz; Montserrat Pinto-Croker; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2115.

ARVO Annual Meeting Abstract June 2022

Results of a Phase 1b clinical trial of KPI-012, a novel secretome therapy, in patients with Persistent Corneal Epithelial Defect (PCED)

Valeria Sanchez-Huerta; Enrique O Graue-Hernandez; Alejandro Navas; Hugo Quiroz-Mercado; Spencer Alford; Darius Kharabi; Stephen C Pflugfelder

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3232 – A0267.

Articles April 2022

Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy

PDF

Jesse M. Smith; Nikhil Mandava; Vanessa Tirado-Gonzalez; Rodrigo Garcia-Santisteban; Matthew D. Geiger; Jennifer L. Patnaik; Ashley Frazer-Abel; Anne M. Lynch; Naresh Mandava; V. Michael Holers; Brandie D. Wagner; Idaira Sanchez-Santos; Daniela Meizner; Hugo Quiroz-Mercado; Alan G. Palestine
TAGS: complement system proteins, diabetic retinopathy, proliferative diabetic retinopathy, vitreous body, complement activation
Trans. Vis. Sci. Tech.. 2022; 11(4):13. https://doi.org/10.1167/tvst.11.4.13

ARVO Annual Meeting Abstract June 2021

Neuroprotective Effect of Risuteganib on Retinal Neurons in an Excitotoxic Injury Cell Culture Model and a Mechanical Injury Rat Model

Lenin David Ochoa-de la Paz; Roberto Gonzalez-Salinas; Zixuan Shao; John Y Park; Hampar L Karageozian; Vicken H Karageozian; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3003.

ARVO Annual Meeting Abstract June 2021

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study

Roberto Gonzalez-Salinas; Elizabeth Yeu; Hugo Quiroz-Mercado; Nallely Ramos-Betancourt; Claudia Corredor-Ortega; Juan Carlos Ceballos Galvez; Martha Massaro-Corredor; Stephanie N. Baba; Mark J. Holdbrook

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1332.

Retina September 2020

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy

PDF

Nikhil Mandava; Vanessa Tirado-Gonzalez; Matthew D. Geiger; Jennifer L. Patnaik; Ashley Frazer-Abel; Anne M. Lynch; Naresh Mandava; Alan G. Palestine; V. Michael Holers; Brandie D. Wagner; Idaira Sanchez-Santos; Daniela Meizner; Hugo Quiroz-Mercado; Jesse M. Smith
TAGS: complement activation, complement system proteins, diabetic retinopathy, proliferative diabetic retinopathy, vitreous body, plasma, eye, diabetes mellitus
Invest. Ophthalmol. Vis. Sci.. 2020; 61(11):39. https://doi.org/10.1167/iovs.61.11.39

ARVO Annual Meeting Abstract June 2020

Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration

Raj Maturi; Glenn J Jaffe; Justis P Ehlers; Peter K Kaiser; David S Boyer; Jeffrey S Heier; Julia A Kornfield; Baruch D Kuppermann; Hugo Quiroz-Mercado; Janine Aubel; Lisa Karageozian; Vicken H Karageozian; Melvin Sarayba

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1944.

ARVO Annual Meeting Abstract June 2020

Pilot Study to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Blepharitis Due to Demodex Infestation (Mars Study)

Hugo Quiroz-Mercado; Nallely Ramos-Betancourt; Claudia Corredor-Ortega; Juan C Ceballos; Martha G Massaro-Corredor; Stephanie N Baba; Mark J Holdbrook; Roberto Gonzalez-Salinas

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2984.

ARVO Annual Meeting Abstract July 2019

Plasma and Vitreous Complement Levels in Humans with Proliferative Diabetic Retinopathy

Nikhil Kenneth Mandava; Vanessa Tirado; Matthew D. Geiger; Jennifer Patnaik; Ashley Frazer-Abel; Anne Lynch; Naresh Mandava; Alan Palestine; Michael Holers; Brandie D Wagner; Idaira Sanchez-Santos; Daniela Meizner; Hugo Quiroz-Mercado; Jesse Smith

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6552.

ARVO Annual Meeting Abstract July 2019

Fundus autofluorescence in premature infants

Yurico Lopez; Ana Gonzalez-H.Leon; Santiago Soberón; Selene Rodríguez; Luis Daniel Garcia Arzate; Anri Pérez-Nakano; Jazmin Baca Moreno; Elsa Cynthia Hernández Piñamora; Enrique Garcia; Vanessa Tirado; Karen Jazmín Herrera-Juárez; Gerardo García-Aguirre; Virgilio Morales-Canton; Hugo Quiroz-Mercado; Guillermo Salcedo- Villanueva

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1560.

ARVO Annual Meeting Abstract July 2019

Evaluation of acquired color vision deficiency in patients with primary open angle glaucoma with Rabin Cone Contrast Test

Elsa Cynthia Hernández Piñamora; Enrique Garcia; Vanessa Tirado; Yurico Lopez; Jazmin Baca Moreno; Luis Daniel García Azarte; Santiago Soberón; Ana Gonzalez-H.Leon; Jans J Fromow-Guerra; Virgilio Morales-Canton; Luis A. Hernández; Nallely Ramos Betancourt; Pablo A. Juarez; Marco Beltran; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2489.

ARVO Annual Meeting Abstract July 2019

Evaluation of Risuteganib as a neuroprotective agent in retinal dystrophy, using the Rabin cone contrast test

Vanessa Tirado; Luis A. Hernández; Santiago Soberón; Elsa C. Hernández; Jazmin Baca Moreno; Enrique Garcia; Luis Daniel Garcia Arzate; Yurico Lopez; Ana Gonzalez-H.Leon; Ana Suárez Licona; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):45.

ARVO Annual Meeting Abstract July 2019

Evaluation of acquired color vision deficiency in patients with primary open angle glaucoma with Rabin Cone Contrast Test and its correlation to the nerve fiber layer thickness

Luis Alfonso Hernandez; Elsa Cynthia Hernández Piñamora; Enrique Garcia; Vanessa Tirado; Santiago Soberón; Ana Gonzalez-H.Leon; Yurico Lopez; Luis Daniel Garcia Arzate; Jazmin Baca Moreno; Jans Fromow-Guerra; Pablo A. Juarez; Marco Beltran; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6151.

ARVO Annual Meeting Abstract July 2019

EVALUATION OF CONE FUNCTION IN DIABETIC RETINOPATHY WITH AND WITHOUT MACULAR EDEMA USING THE RABIN CONE CONTRAST TEST

Maria Lucia Urani; Idaira Sánchez Santos; Vanessa Tirado; Jazmin Baca Moreno; Santiago Soberón; Roberto Gonzalez-Salinas; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2647.

ARVO Annual Meeting Abstract July 2019

Intravitreal bromfenac with liposomes. A toxicology study in rabbit eyes.

Idaira Sánchez Santos; Gustavo Adolfo García; Mónica Anayatzin Alba; Rodrigo García Santisteban; Luis Daniel García Azarte; Roberto González Salinas; María Lucía Urani; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2729.

ARVO Annual Meeting Abstract July 2019

Stargardt disease: Rapid quantification of color vision using the Rabin Cone Contrast Test

Santiago Soberón; Vanessa Tirado; Guillermo Salcedo- Villanueva; Luis A. Hernández; Elsa C. Hernández; Jazmin Baca Moreno; Luis Daniel Garcia Arzate; Enrique Garcia; Yurico Lopez; Ana Gonzalez-H.Leon; Ana Suárez Licona; Roberto Gonzalez-Salinas; Virgilio Morales-Canton; Hugo Quiroz-Mercado

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5017.

ARVO Annual Meeting Abstract July 2019

Protective effects of Risuteganib® against inflammation and oxidative stress on a Dry Eye Disease experimental model on C57BL / 6J mice

Hugo Quiroz-Mercado; LUIS F HERNANDEZ; Ivan Ramos-Martínez; Ruben Zamora-Alvarado; Lenin Ochoa-de la Paz; Anri Pérez-Nakano; Roberto Gonzalez-Salinas

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):288.

ARVO Annual Meeting Abstract July 2018

Cytoprotective effect of ALG-1001 peptide (Luminate) on human retinal pigment epithelial cells exposed to oxidative injury. A novel functional-outcome for an anti-VEGF agent.

Marco A Beltran; Ruben Zamora-Alvarado; Roberto Gonzalez-Salinas; Rosario Gulias-Cañizo; Hugo Quiroz-Mercado; LUIS F HERNANDEZ; Hampar Karageozian; Vicken H Karageozian; John Y Park; Lenin Ochoa-de la Paz

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1465.

ARVO Annual Meeting Abstract July 2018

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Hugo Quiroz-Mercado; David S Boyer; Peter A Campochiaro; Jeffrey S. Heier; Peter K Kaiser; Julie Kornfield; Baruch D Kuppermann; Vicken H Karageozian; Hampar L Karageozian; Lisa Karageozian; John Y Park; Melvin Sarayba

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1960.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Employing Large Language Models (LLMs) for study candidate selection and clinical data extraction in the context of retinal research.

SAFETY PROFILE OF SUBRETINAL INJECTION OF HUMAN AMNIOTIC MEMBRANE UMBILICAL CORD PARTICULATE IN PIGS

Results of a Phase 1b clinical trial of KPI-012, a novel secretome therapy, in patients with Persistent Corneal Epithelial Defect (PCED)

Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy

Neuroprotective Effect of Risuteganib on Retinal Neurons in an Excitotoxic Injury Cell Culture Model and a Mechanical Injury Rat Model

Safety and Efficacy of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: The EUROPA Study

Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy

Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration

Pilot Study to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Blepharitis Due to Demodex Infestation (Mars Study)

Plasma and Vitreous Complement Levels in Humans with Proliferative Diabetic Retinopathy

Fundus autofluorescence in premature infants

Evaluation of acquired color vision deficiency in patients with primary open angle glaucoma with Rabin Cone Contrast Test

Evaluation of Risuteganib as a neuroprotective agent in retinal dystrophy, using the Rabin cone contrast test

Evaluation of acquired color vision deficiency in patients with primary open angle glaucoma with Rabin Cone Contrast Test and its correlation to the nerve fiber layer thickness

EVALUATION OF CONE FUNCTION IN DIABETIC RETINOPATHY WITH AND WITHOUT MACULAR EDEMA USING THE RABIN CONE CONTRAST TEST

Intravitreal bromfenac with liposomes. A toxicology study in rabbit eyes.

Stargardt disease: Rapid quantification of color vision using the Rabin Cone Contrast Test

Protective effects of Risuteganib® against inflammation and oxidative stress on a Dry Eye Disease experimental model on C57BL / 6J mice

Cytoprotective effect of ALG-1001 peptide (Luminate) on human retinal pigment epithelial cells exposed to oxidative injury. A novel functional-outcome for an anti-VEGF agent.

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

To View More...

You must be signed into an individual account to use this feature.